Metoprolol Succinate Tablet, Extended Release
Product Images NDC 68382-565

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 68382-565). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

118706c2 F03f 4175 Aba2 4f0cddb75ae7 01

Chemical structure diagram of metoprolol succinate, showing the molecular composition and arrangement of the active ingredient.*

FDA Label Image

118706c2 F03f 4175 Aba2 4f0cddb75ae7 02

A forest plot chart titled 'Results for Subgroups in MERIT-HF' showing comparative relative risk and 95% confidence intervals for metoprolol succinate versus placebo. It presents data across various subgroups (e.g., NYHA class, ejection fraction, ischemic etiology, sex, race, medical history) for outcomes including total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure. The chart visually indicates which treatment favors metoprolol succinate or placebo.*

FDA Label Image

118706c2 F03f 4175 Aba2 4f0cddb75ae7 03

Label for metoprolol succinate extended-release tablets, USP, 25 mg strength, oral dosage form. The label indicates a package of 100 tablets with prescription-only status. The product is manufactured by Zydus Lifesciences Ltd., India, and distributed by Zydus Pharmaceuticals (USA) Inc. Storage instructions and safety warnings are included. The NDC number 68382-564-01 is shown.*

FDA Label Image

118706c2 F03f 4175 Aba2 4f0cddb75ae7 04

Label for metoprolol succinate extended-release tablets, USP, 50 mg strength. The label indicates 100 tablets per package, for prescription use only. It includes manufacturer and distributor information: manufactured by Zydus Lifesciences Ltd., India, and distributed by Zydus Pharmaceuticals (USA) Inc. Dosage form is oral extended-release tablets.*

FDA Label Image

118706c2 F03f 4175 Aba2 4f0cddb75ae7 05

Label for Metoprolol Succinate Extended-Release Tablets, USP 100 mg by Zydus Pharmaceuticals (USA) Inc. The label includes the NDC 68382-566-01, a barcode, and states the package contains 100 tablets for oral use. Instructions include storage temperature, child resistance, and dispensing guidance. Manufacturer is Zydus Lifesciences Ltd., India.*

FDA Label Image

118706c2 F03f 4175 Aba2 4f0cddb75ae7 06

Label for metoprolol succinate extended-release tablets, USP, 200 mg strength. The label indicates a package containing 100 tablets, for oral use, and is marked as Rx only. The labeler is Zydus Pharmaceuticals (USA) Inc. with manufacturing by Zydus Lifesciences Ltd. The label includes storage instructions and safety warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.